Free Trial

Semler Scientific Q3 2023 Earnings Report

Semler Scientific logo
$61.78 +0.44 (+0.72%)
(As of 12/20/2024 05:51 PM ET)

Semler Scientific EPS Results

Actual EPS
$0.71
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Semler Scientific Revenue Results

Actual Revenue
$16.32 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Semler Scientific Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

Semler Scientific Earnings Headlines

Semler Scientific announces updated BTC, ATM activity
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
See More Semler Scientific Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Semler Scientific? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Semler Scientific and other key companies, straight to your email.

About Semler Scientific

Semler Scientific (NASDAQ:SMLR) provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

View Semler Scientific Profile

More Earnings Resources from MarketBeat

Upcoming Earnings